No definition available.
Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)
C3_STOMACH_NEUROENDOCRINE_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
160 |
4. Check minimum number of eventsNone |
160 |
5. Include endpointsNone |
160 |
6. Filter based on genotype QC (FinnGen only) |
160 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Neuroendocrine tumor and carcinoma of stomach
- Malignant neoplasm of stomach
- Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 160 | 84 | 76 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 62.11 | 59.36 | 65.16 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 149
- Matched controls
- 1491
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K29.4
ICD-10 Finland
Chronic atrophic gastritis
110.3
82.7
86
18
8240/3-C16.9
ICD-O-3
Neuroendocrine tumor, NOS, of stomach, NOS
+∞
78.2
68
*
B03BA03
ATC
hydroxocobalamin; parenteral
51.2
78.0
97
52
107
Kela drug reimbursment
Pernicious anaemia
61.2
59.1
68
20
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
21.5
56.7
124
279
B81
ICPC
Anaemia vit B12/folate deficiency
40.1
51.3
65
28
8240/3-C16.2
ICD-O-3
Neuroendocrine tumor, NOS, of body of stomach
+∞
46.3
42
*
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
43.1
46.1
57
21
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
534.2
42.4
40
*
130
Kela drug reimbursment
Malignant tumour
+∞
26.9
25
*
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
74.4
22.6
25
*
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
15.9
15
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
15.9
15
*
UJD02
NOMESCO Finland
Gastroscopy
10.9
14.5
28
31
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
+∞
13.8
13
*
A50
ICPC
General and Unspecified, Medication/prescr/renewal
13.4
12.3
21
18
JDA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in stomach or pylorus
+∞
10.5
10
*
D51.0
ICD-10 Finland
Vitamin B12deficiency anaemia due to intrinsic factor deficiency
35.3
10.5
13
*
UJF32
NOMESCO Finland
Coloscopy
3.5
10.5
59
233
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
21.9
10.0
14
7
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
19.1
9.6
14
8
H02AB02
ATC
dexamethasone; systemic
23.5
9.5
13
6
8240/3-C16.0
ICD-O-3
Neuroendocrine tumor, NOS, of cardia, NOS
+∞
9.5
9
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
29.5
8.6
11
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
8.4
8
*
H01CB02
ATC
octreotide; parenteral
+∞
8.4
8
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
5.3
8.2
25
55
A10AE04
ATC
insulin glargine; parenteral
4.7
7.9
27
67
D64.9
ICD-10 Finland
Anaemia, unspecified
4.5
7.6
27
70
C61
ICD-10 Finland
Malignant neoplasm of prostate
84.1
7.5
8
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
7.3
7
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
-50
ICPC
Medication/prescr/renewal
6.7
7.0
17
28
K31.7
ICD-10 Finland
Polyp of stomach and duodenum
42.0
6.8
8
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.9
6.7
21
48
H03AA01
ATC
levothyroxine sodium; systemic
2.7
6.5
50
232
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
19.0
6.3
9
5
S50
ICPC
Skin, Medication/prescr/renewal
28.0
6.3
8
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
8249/3-C16.9
ICD-O-3
Neuroendocrine tumor, grade 2 of stomach, NOS
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
6.3
6
*
8249/3-C16.2
ICD-O-3
Neuroendocrine tumor, grade 2 of body of stomach
+∞
6.3
6
*
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
+∞
6.3
6
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
6.2
40
164
JN4AD
NOMESCO Finland
Body CT examination
6.3
6.0
15
26
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_STOMACH_NEUROENDOCRINE_EXALLC – Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).